Baltic Charles V. III 4
4 · MEI Pharma, Inc. · Filed Jul 7, 2020
Insider Transaction Report
Form 4
MEI Pharma, Inc.MEIP
Baltic Charles V. III
Director
Transactions
- Award
Stock Option (Right to Buy)
2020-07-02+50,000→ 50,000 totalExercise: $3.49Exp: 2030-07-02→ Common Stock (50,000 underlying)
Holdings
- 40,000
Stock Option (Right to Buy)
Exercise: $4.28Exp: 2028-07-12→ Common Stock (40,000 underlying) - 20,000
Stock Option (Right to Buy)
Exercise: $1.57Exp: 2025-07-28→ Common Stock (20,000 underlying) - 40,000
Stock Option (Right to Buy)
Exercise: $1.36Exp: 2026-07-29→ Common Stock (40,000 underlying) - 40,000
Stock Option (Right to Buy)
Exercise: $2.52Exp: 2029-07-01→ Common Stock (40,000 underlying) - 40,000
Stock Option (Right to Buy)
Exercise: $2.83Exp: 2027-07-06→ Common Stock (40,000 underlying)
Footnotes (2)
- [F1]The options will vest in equal monthly installments over twelve months.
- [F2]All of such options are presently exercisable.